Question

Will semaglutide be a top 300 medicine in America before 2032?

Resolved :Yes93%

8 comments8

Total Forecasters41

Community Prediction93% (89% - 99%)

Make a Prediction

50%

community: 93%

Did this actually happen?Yes

Community Baseline Score

1.4

Community Peer Score

0.1

Authors:

EvanHarper

Opened:

Jun 8, 2021

Closes:

Jan 1, 2032

Resolves:

Jan 1, 2032

Health & Pandemics

Economy & Business

Food and Drug Administration

Glucagon-like peptide-1 receptor agonist

Crackdown on Ozempic, Wegovy Hits Thousands In Colorado

Newsweek•Jan 24, 2025

Eli Lilly's head of obesity talks weight-loss innovations for 2025 — from an Ozempic-like pill to a triple-threat shot

Business Insider•Jan 26, 2025

People Taking Ozempic Are Spending Less Money on Groceries

Newsweek•Jan 27, 2025

Learn more about Metaculus NewsMatch

Will oral semaglutide be approved for the treatment of obesity by the FDA or EMA by 2027?

80.8%

Will the FDA or EMA withdraw approval of Semaglutide for the treatment of obesity by 2027?

Will a small molecule GLP-1-based drug be approved for the treatment of obesity by the FDA or EMA by 2029?

59.7%

Comments

? comments

Authors:

EvanHarper

Opened:

Jun 8, 2021

Closes:

Jan 1, 2032

Resolves:

Jan 1, 2032

Health & Pandemics

Economy & Business

Food and Drug Administration

Glucagon-like peptide-1 receptor agonist

Crackdown on Ozempic, Wegovy Hits Thousands In Colorado

Newsweek•Jan 24, 2025

Eli Lilly's head of obesity talks weight-loss innovations for 2025 — from an Ozempic-like pill to a triple-threat shot

Business Insider•Jan 26, 2025

People Taking Ozempic Are Spending Less Money on Groceries

Newsweek•Jan 27, 2025

Learn more about Metaculus NewsMatch

Will oral semaglutide be approved for the treatment of obesity by the FDA or EMA by 2027?

80.8%

Will the FDA or EMA withdraw approval of Semaglutide for the treatment of obesity by 2027?

Will a small molecule GLP-1-based drug be approved for the treatment of obesity by the FDA or EMA by 2029?

59.7%